Obinutuzumab for PLA2R-associated membranous nephropathy
Nephrology Dialysis Transplantation · 26.11.2025 · 40 (12) · 2401-2403
DOI: 10.1093/ndt/gfaf165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 20.08.2025. Verfasst von Guo-Qing Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Nephrology, Northeast Electric Power Central Hospital of Liaoning, Shenyang, Liaoning, China.
Zitieren
APA
Shi, G. Q., Yu, R., Wu, Y., Zhou, H., Zhao, Z. X., Zheng, X. M., Wang, Y. Q., Zhang, B. R., & Zhang, Y. Z. (2025). Obinutuzumab for PLA2R-associated membranous nephropathy. Nephrology Dialysis Transplantation, 40(12), 2401-2403. https://doi.org/10.1093/ndt/gfaf165
Vancouver
Shi GQ, Yu R, Wu Y, Zhou H, Zhao ZX, Zheng XM, et al. Obinutuzumab for PLA2R-associated membranous nephropathy. Nephrology Dialysis Transplantation. 2025;40(12):2401-2403. doi:10.1093/ndt/gfaf165
BibTeX
@article{Shi2025,
author = {Shi, Guo-Qing and Yu, Rui and Wu, Yan and Zhou, Hua and Zhao, Zi-Xia and Zheng, Xiao-Min and Wang, Yan-Qiu and Zhang, Bei-Ru and Zhang, Yong-Zhe},
title = {Obinutuzumab for PLA2R-associated membranous nephropathy},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
volume = {40},
number = {12},
pages = {2401--2403},
doi = {10.1093/ndt/gfaf165}
}
EUVIMED